Table 3 American Diabetes Association (ADA) Classification at Baseline1
Parameter | ADA Classification | Placebo (N = 17) | 3 g/d BBG (N = 16) | 6 g/d BBG (N = 17) | p-value2 |
|---|---|---|---|---|---|
Fasting Plasma Glucose (mg/dL) | Normal: Fasting Plasma Glucose < = 99 mg/dL | 9; 95.1 (1.3) | 6; 91.7 (2.9) | 7; 91.0 (2.5) | 0.335 |
Impaired: Fasting Plasma Glucose 100- 125 mg/dL | 8; 110.3 (2.4) | 9; 108.2 (2.1) | 10; 105.6 (1.0) | 0.218 | |
Diabetes Mellitus: Fasting Plasma Glucose >= 126 mg/dL | 1; 145.0 | ||||
OGTT (mg/dL): 2 hrs post dose | Normal: Glucose at 2 hours < = 139 mg/dL | 9; 94.6 (7.7) | 11; 101.3 (8.0) | 13; 103.5 (6.8) | 0.699 |
Impaired: Glucose at 2 hours 140-199 mg/dL | 5; 169.6 (8.1) | 3; 176.3 (13.9) | 3; 160.3 (3.7) | 0.568 | |
Diabetes Mellitus: Glucose at 2 hours >= 200 mg/dL | 3; 212.0 (5.0) | 2; 229.5 (2.5) | 1; 201.0 | 0.093 |